Evidence map›Paper›PMID 39061150›Full record

ReviewCancers2024

Impact of Driver Mutations on Metastasis-Free Survival in Uveal Melanoma: A Meta-Analysis.

David Lamas-Francis, Carmen Antía Rodríguez-Fernández, Elia de Esteban-Maciñeira, Paula Silva-Rodríguez, María Pardo, Manuel Bande-Rodríguez, María José Blanco-Teijeiro

Abstract readReview
In one paragraph

Review in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Gene therapy for uveal melanoma.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  2. Review
  3. ElevatedCancer genomics & proteomics · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

David Lamas-FrancisDepartment of Ophthalmology, University Hospital of Santiago de Compostela, 15706 Santiago de Compostela, Spain.ORCID 0000-0001-9867-8773
Carmen Antía Rodríguez-FernándezDepartment of Ophthalmology, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.ORCID 0000-0002-9179-8163
Elia de Esteban-MaciñeiraDepartment of Ophthalmology, University Hospital of Santiago de Compostela, 15706 Santiago de Compostela, Spain.ORCID 0000-0002-2247-1343
Paula Silva-RodríguezFundación Pública Galega de Medicina Xenómica, 15706 Santiago de Compostela, Spain.
María PardoObesidomics Group, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain.ORCID 0000-0002-9967-1650
Manuel Bande-RodríguezDepartment of Ophthalmology, University Hospital of Santiago de Compostela, 15706 Santiago de Compostela, Spain.
María José Blanco-TeijeiroDepartment of Ophthalmology, University Hospital of Santiago de Compostela, 15706 Santiago de Compostela, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prognosis of uveal melanoma is significantly influenced by the risk of metastasis, which varies according to clinical and genetic features. Driver mutations can predict the likelihood of disease progression and survival, although the data in the literature are inconsistent. This meta-analysis aimed to evaluate the prognostic significance of driver mutations, including

Indexed as

BAP1driver mutationsGNA11GNAQSF3B1survivaluveal melanoma

Identifiers

PMID39061150
PMCPMC11274588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.